| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_399d426408ce1e752b8d3915985741a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bd433e19d43c4d9b2a68ed8443b9a9a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 |
| filingDate |
2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68e6a558abc6c7a70e2e9c69dacb9462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c902ca63f40b929947dff27f207ece2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09b169ab9e32a4ef3353549645d9e180 |
| publicationDate |
2011-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110122218-A |
| titleOfInvention |
Antifungal Pharmaceutical Compositions |
| abstract |
Acetone, polyoxyethylene alkyl (having 8 to 30 carbon atoms) ethers, and / or poly in external pharmaceutical compositions containing compounds such as uliconazole and / or salts thereof in an amount of 5% by mass or more Oxyethylene alkenyl (with 8 to 30 carbon atoms) ethers are included. Formulations having solvents other than crotamiton, propylene carbonate, and N-methyl-2-pyrrolidone as solvents for solubilization and steric stabilization and having the following properties are provided: 1) When the compound represented by the formula (1) and / or its salts have stereoisomers, the amount of the stereoisomer of the compound and / or its salts produced under the preservation conditions of 60 ° C. for 3 weeks is the compound and // Or 1 mass% or less with respect to the total mass of its salts; 2) The formulation is a clear liquid when stored at a constant temperature of 20 ° C. immediately after preparation; And 3) The formulation does not precipitate crystals when stored at 5 ° C. for 2 weeks after preparation. |
| priorityDate |
2009-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |